In lung squamous cell cancer (SCC) and in hepatocellular carcinoma, Gli expression has been shown to be inversely correlated with E-Cadherin expression and in lung SCC inhibition of the SHh pathway increases E-Cadherin expression [26, 27]. The gene discussed is GLI1; the disease is hepatocellular carcinoma.